VMP1 related autophagy and apoptosis in colorectal cancer cells: VMP1 regulates cell death

https://doi.org/10.1016/j.bbrc.2013.12.090Get rights and content

Highlights

  • •

    This research confirmed VMP1 as a regulator of autophagy in colorectal cancer cell lines.

  • •

    We proved the pro-survival role of VMP1-mediated autophagy in colorectal cancer cell lines.

  • •

    We found the interaction between VMP1 and BECLIN1 also existing in colorectal cancer cell lines.

Abstract

Vacuole membrane protein 1 (VMP1) is an autophagy-related protein and identified as a key regulator of autophagy in recent years. In pancreatic cell lines, VMP1-dependent autophagy has been linked to positive regulation of apoptosis. However, there are no published reports on the role of VMP1 in autophagy and apoptosis in colorectal cancers. Therefore, to address this gap of knowledge, we decided to interrogate regulation of autophagy and apoptosis by VMP1. We have studied the induction of autophagy by starvation and rapamycin treatment in colorectal cell lines using electron microscopy, immunofluorescence, and immunoblotting. We found that starvation-induced autophagy correlated with an increase in VMP1 expression, that VMP1 interacted with BECLIN1, and that siRNA mediated down-regulation of VMP1-reduced autophagy. Next, we examined the relationship between VMP1-dependent autophagy and apoptosis and found that VMP1 down-regulation sensitizes cells to apoptosis and that agents that induce apoptosis down-regulate VMP1. In conclusion, similar to its reported role in other cell types, VMP1 is an important regulator of autophagy in colorectal cell lines. However, in contrast to its role in pancreatic cell lines, in colorectal cancer cells, VMP1-dependent autophagy appears to be pro-survival rather than pro-cell death.

Introduction

Colorectal cancer (CRC) is one of the most common digestive cancers worldwide. Although the prognosis of CRC has improved in recent years because of combined therapy, the prognosis of advanced CRC with lymphatic metastasis remains poor because there is no efficacious therapy for advanced CRC [1]. Resistance to chemotherapy is a vital problem associated with poor prognosis and problems with treatment [2]. Substantial evidence indicates that autophagy is a mechanism contributing to chemoresistance in colorectal cancer cells [3].

Autophagy is an evolutionarily conserved process that plays a role in the turnover of old organelles and proteins to obtain energy. The role of autophagy in tumors is contradictory. There is evidence describing the different roles of autophagy depending on the type of tumor [4], [5], [6], [7], [8]. In colorectal cancer cells, more evidence tends to describe autophagy as a pro-survival tumor cell behavior, enhancing the aggressiveness of tumor cells and their ability to adapt to apoptotic stimuli, starvation or anti-tumor drugs [9], [10].

Autophagy is regulated by specific genes known as ATGs (autophagy-related genes). Many ATG proteins have been identified, including vacuole membrane protein 1 (VMP1), which is very active in acinar cells during acute pancreatitis [11]. VMP1 interacts with BECLIN1 through its target lipid kinase Vps34/PI3KC3 to assemble a class III PI3K complex, which positively regulates the formation of autophagosomes.

To date, several reports have demonstrated anti-tumor functions of VMP1. In hepatocellular carcinoma, VMP1 has been shown to inhibit proliferation and metastasis [13], and in pancreatic cell lines, inhibition of VMP1 decreased apoptosis [14]. Though there is evidence that in non-small lung cancers, expression of VMP1 has been linked to poor prognosis [12]. To our knowledge, a pro-tumorigenic role of VMP1 has not been reported in colorectal cancer.

Given the lack of any report on the role of VMP1 in colorectal cancers, we decided to test how VMP1 regulates autophagy and apoptosis in this type of cancer. We used several different colorectal cancer cell lines to confirm whether autophagy occurs in these cells when under stress or autophagic-inducing conditions and to determine whether VMP1 regulates autophagy in these cells by interacting with BECLIN1. This is the first report investigating the role of VMP1 in colorectal cancer and the first one to demonstrate a pro-survival (and presumably pro-tumorigenic) role of the gene.

Section snippets

Cells and culture conditions

SW480 cells were cultured in Leibovitz’s L-15 medium (Invitrogen, Carlsbad, CA, USA) with 10% FBS at 37 °C in a humidified atmosphere of 5% CO2. The cells were treated with etoposide (Sigma–Aldrich, Shanghai, China) at 5 μg/ml or the apoptosis-inducing agent staurosporine (Sigma–Aldrich, Shanghai, China) at 2 μM, unless otherwise indicated. Rapamycin (Invitrogen, Carlsbad, CA, USA) was used as indicated. All of the agents were dissolved in DMSO.

RNA interference

VMP1-siRNA#1 (described previously [12]) and

Serum deprivation-induced autophagy is associated with an upregulation of VMP1 in colorectal cancer cell

To confirm that serum starvation or rapamycin treatment would induce autophagy in colorectal cancer cells, SW480 cells were treated will serum-free medium or rapamycin and were examined by transmission electron microscopy (TEM). Starvation and rapamycin treatment strongly induced autophagy as judged by formation of autophagosomes in Fig. 1A. The microtubule-associated protein 1 light chain 3 (LC3) is a homologue of Apg8p for autophagy in yeast, which is a marker of autophagy formation. The

Discussion

VMP1 is a promoter of autophagy in many cell types [12], but the role of VMP1 in colorectal cancer is unknown. In this study, we focused on investigating the function of VMP1 in autophagy and apoptosis. Similar to its role in other cell lines, in colorectal cancer cell lines, VMP1 is involved in induction of autophagy; in contrast to pancreatic cell lines, VMP1-dependent autophagy is a pro-survival mechanism. Additionally, our results indicate that VMP1 induces autophagy in colorectal cancer

Disclosure statement

The authors have no conflicts of interest.

Acknowledgment

We are thankful for the assistance of Mr. Gang Yang (Department of Electron Microscopy, Soochow University) with the TEM procedures.

References (29)

  • A. Grothey et al.

    Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line

    J. Clin. Oncol.

    (2005)
  • T. Troiani et al.

    Molecular aspects of resistance to biological and non-biological drugs and strategies to overcome resistance in colorectal cancer

    Curr. Med. Chem.

    (2013)
  • K. Jain et al.

    Autophagy in breast cancer and its implications for therapy

    Am. J. Cancer Res.

    (2013)
  • M.T. Lotze et al.

    Inhibiting autophagy: a novel approach for the treatment of renal cell carcinoma

    Cancer J.

    (2013)

    • Cited by (17)

    View all citing articles on Scopus
    1

    These authors are joint first authors; they contributed equally to this work.

    View full text
    Copyright © 2013 Elsevier Inc. All rights reserved.